Thaddeus Cromwell Reeder,Mark Wade Moore,Douglas Alan Lorenz,David Keith Lyon
申请号：
US15365843
公开号：
US09980978B2
申请日:
2016.11.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine.
